| 17beta-estradiol | increases expression | ISO | RGD:1604404 | 6480464 | Estradiol results in increased expression of FOXM1 mRNA | CTD | PMID:18310284 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1604404 | 6480464 | Estradiol results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 PMID:20208560 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1604404 | 6480464 | Tamoxifen inhibits the reaction [Estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mRNA]] | CTD | PMID:20208560 PMID:20208560 |
| 17beta-estradiol | increases response to substance | ISO | RGD:1604404 | 6480464 | FOXM1 protein results in increased susceptibility to Estradiol | CTD | PMID:20208560 |
| 17beta-estradiol | increases expression | ISO | RGD:1604404 | 6480464 | Estradiol results in increased expression of FOXM1 mRNA; more ... | CTD | PMID:20208560 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1604404 | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of FOXM1 mRNA]; more ... | CTD | PMID:20208560 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FOXM1 mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FOXM1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:61807 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FOXM1 mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:61807 | 6480464 | 2,4-dinitrotoluene affects the expression of FOXM1 mRNA | CTD | PMID:21346803 |
| 2,6-di-tert-butyl-4-methylphenol | affects response to substance | EXP | | 6480464 | FOXM1 protein affects the susceptibility to Butylated Hydroxytoluene | CTD | PMID:18345025 PMID:19672312 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA | CTD | PMID:12867420 PMID:11238010 |
| 2,6-di-tert-butyl-4-methylphenol | affects response to substance | EXP | | 6480464 | FOXM1 protein affects the susceptibility to Butylated Hydroxytoluene | CTD | PMID:19672312 PMID:18345025 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of FOXM1 protein | CTD | PMID:11238010 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | [Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNA2 mRNA; more ... | CTD | PMID:12867420 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA | CTD | PMID:11238010 PMID:12867420 |
| 2,6-di-tert-butyl-4-methylphenol | affects localization | EXP | | 6480464 | Butylated Hydroxytoluene affects the localization of FOXM1 mRNA | CTD | PMID:12867420 |
| 3-methylcholanthrene | affects response to substance | EXP | | 6480464 | FOXM1 protein affects the susceptibility to Methylcholanthrene | CTD | PMID:19672312 PMID:18345025 |
| 3-methylcholanthrene | affects response to substance | EXP | | 6480464 | FOXM1 protein affects the susceptibility to Methylcholanthrene | CTD | PMID:18345025 PMID:19672312 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of FOXM1 mRNA | CTD | PMID:19191707 |
| aflatoxin B1 | affects expression | ISO | RGD:1604404 | 6480464 | Aflatoxin B1 affects the expression of FOXM1 protein | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1604404 | 6480464 | Benzo(a)pyrene results in decreased expression of FOXM1 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FOXM1 mRNA | CTD | PMID:20713471 |
| calcitriol | decreases expression | ISO | RGD:1604404 | 6480464 | Calcitriol results in decreased expression of FOXM1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1604404 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FOXM1 mRNA | CTD | PMID:21592394 |
| chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of FOXM1 mRNA | CTD | PMID:22135065 |
| chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | NR1H4 affects the reaction [Chenodeoxycholic Acid results in increased expression of FOXM1 mRNA] | CTD | PMID:22135065 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FOXM1 mRNA | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1604404 | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of FOXM1 mRNA | CTD | PMID:21858171 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FOXM1 mRNA | CTD | PMID:21151649 |
| cobalt dichloride | decreases expression | ISO | RGD:1604404 | 6480464 | cobaltous chloride results in decreased expression of FOXM1 mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | decreases expression | ISO | RGD:1604404 | 6480464 | cobaltous chloride results in decreased expression of FOXM1 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1604404 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FOXM1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1604404 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FOXM1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1604404 | 6480464 | Copper Sulfate results in decreased expression of FOXM1 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1604404 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:1604404 | 6480464 | Coumestrol results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1604404 | 6480464 | Cyclosporine results in decreased expression of FOXM1 mRNA | CTD | PMID:20106945 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1604404 | 6480464 | dasatinib results in decreased expression of FOXM1 mRNA | CTD | PMID:20579391 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:1604404 | 6480464 | Tetrahydrocannabinol results in decreased expression of FOXM1 mRNA | CTD | PMID:18454173 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FOXM1 mRNA | CTD | PMID:20938992 |
| fulvestrant | decreases expression | ISO | RGD:1604404 | 6480464 | fulvestrant results in decreased expression of FOXM1 mRNA | CTD | PMID:20208560 PMID:19016759 |
| fulvestrant | decreases expression | ISO | RGD:1604404 | 6480464 | fulvestrant results in decreased expression of FOXM1 mRNA | CTD | PMID:19016759 PMID:20208560 |
| fulvestrant | multiple interactions | ISO | RGD:1604404 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of FOXM1 mRNA | CTD | PMID:19016759 |
| fulvestrant | decreases expression | ISO | RGD:1604404 | 6480464 | fulvestrant results in decreased expression of FOXM1 protein | CTD | PMID:20208560 |
| hydrogen peroxide | decreases expression | ISO | RGD:1604404 | 6480464 | Hydrogen Peroxide results in decreased expression of FOXM1 mRNA | CTD | PMID:12414654 |
| hydrogen peroxide | affects expression | ISO | RGD:1604404 | 6480464 | Hydrogen Peroxide affects the expression of FOXM1 mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FOXM1 mRNA | CTD | PMID:20938992 |
| lucanthone | decreases expression | ISO | RGD:1604404 | 6480464 | Lucanthone results in decreased expression of FOXM1 mRNA | CTD | PMID:21148553 |
| menadione | decreases expression | ISO | RGD:1604404 | 6480464 | Vitamin K 3 results in decreased expression of FOXM1 mRNA | CTD | PMID:12414654 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FOXM1 mRNA | CTD | PMID:13679865 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of FOXM1 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | FOXM1 protein affects the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDC25B protein]; more ... | CTD | PMID:15082532 |
| N-nitrosodiethylamine | increases phosphorylation | EXP | | 6480464 | Diethylnitrosamine results in increased phosphorylation of FOXM1 protein | CTD | PMID:18393292 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of FOXM1 mRNA | CTD | PMID:17854601 |
| paracetamol | increases expression | ISO | RGD:1604404 | 6480464 | Acetaminophen results in increased expression of FOXM1 mRNA | CTD | PMID:22230336 |
| phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FOXM1 mRNA | CTD | PMID:13679865 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of FOXM1 mRNA | CTD | PMID:23091169 |
| phenobarbital | multiple interactions | EXP | | 6480464 | FOXM1 protein affects the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDC25B protein]; more ... | CTD | PMID:15082532 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of FOXM1 mRNA | CTD | PMID:20059764 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of FOXM1 mRNA] | CTD | PMID:20059764 |
| piroxicam | multiple interactions | ISO | RGD:1604404 | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of FOXM1 mRNA | CTD | PMID:21858171 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of FOXM1 mRNA | CTD | PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | EXP | | 6480464 | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in increased expression of FOXM1 mRNA] | CTD | PMID:22698814 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of FOXM1 mRNA | CTD | PMID:21278054 |
| quercetin | increases expression | ISO | RGD:1604404 | 6480464 | Quercetin results in increased expression of FOXM1 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1604404 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 |
| resveratrol | increases expression | ISO | RGD:1604404 | 6480464 | resveratrol results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 |
| sirolimus | multiple interactions | ISO | RGD:1604404 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of FOXM1 mRNA | CTD | PMID:19016759 |
| tamoxifen | multiple interactions | ISO | RGD:1604404 | 6480464 | ESR1 protein inhibits the reaction [Tamoxifen results in decreased expression of FOXM1 mRNA]; more ... | CTD | PMID:20208560 |
| tamoxifen | multiple interactions | ISO | RGD:1604404 | 6480464 | Tamoxifen inhibits the reaction [Estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mRNA]] | CTD | PMID:20208560 PMID:20208560 |
| tamoxifen | decreases expression | ISO | RGD:1604404 | 6480464 | Tamoxifen results in decreased expression of FOXM1 mRNA; more ... | CTD | PMID:20208560 |
| tamoxifen | decreases response to substance | ISO | RGD:1604404 | 6480464 | FOXM1 protein results in decreased susceptibility to Tamoxifen | CTD | PMID:20208560 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1604404 | 6480464 | tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA | CTD | PMID:15336504 PMID:12414654 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1604404 | 6480464 | tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA | CTD | PMID:12414654 PMID:15336504 |
| testosterone | multiple interactions | ISO | RGD:1604404 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FOXM1 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1604404 | 6480464 | Testosterone results in decreased expression of FOXM1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:61807 | 6480464 | Carbon Tetrachloride results in increased expression of FOXM1 mRNA | CTD | PMID:17256749 |
| trans-resveratrol | multiple interactions | ISO | RGD:1604404 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases expression | ISO | RGD:1604404 | 6480464 | resveratrol results in increased expression of FOXM1 mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of FOXM1 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:1604404 | 6480464 | troglitazone results in decreased expression of FOXM1 mRNA | CTD | PMID:19140230 |
| urethane | affects response to substance | EXP | | 6480464 | FOXM1 protein affects the susceptibility to Urethane | CTD | PMID:19672312 |
| urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FOXM1 protein | CTD | PMID:16489016 |